H. Mengel

863 total citations
23 papers, 625 citations indexed

About

H. Mengel is a scholar working on Psychiatry and Mental health, Pharmacology and Molecular Biology. According to data from OpenAlex, H. Mengel has authored 23 papers receiving a total of 625 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Psychiatry and Mental health, 7 papers in Pharmacology and 6 papers in Molecular Biology. Recurrent topics in H. Mengel's work include Epilepsy research and treatment (8 papers), Treatment of Major Depression (6 papers) and Pharmacological Effects and Toxicity Studies (5 papers). H. Mengel is often cited by papers focused on Epilepsy research and treatment (8 papers), Treatment of Major Depression (6 papers) and Pharmacological Effects and Toxicity Studies (5 papers). H. Mengel collaborates with scholars based in Denmark, Germany and United Kingdom. H. Mengel's co-authors include Linda E. Gustavson, Niranjan Rao, Birgitte Søgaard, Frank Larsen, Ole Karlog, Marianne Mikkelsen, W. Kŕause, L. F. Gram, Henrik Loft and L. J. Thal and has published in prestigious journals such as Neurology, International Journal of Pharmaceutics and Life Sciences.

In The Last Decade

H. Mengel

22 papers receiving 580 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H. Mengel Denmark 13 310 219 216 167 94 23 625
M. L. Jack United States 14 187 0.6× 163 0.7× 145 0.7× 134 0.8× 93 1.0× 15 762
K. H. Antonin Germany 16 261 0.8× 226 1.0× 229 1.1× 203 1.2× 135 1.4× 36 954
M. Gerna Italy 16 235 0.8× 153 0.7× 243 1.1× 110 0.7× 119 1.3× 18 662
F. Bengtsson Sweden 14 141 0.5× 174 0.8× 62 0.3× 121 0.7× 87 0.9× 30 600
Morselli Pl Italy 16 228 0.7× 125 0.6× 120 0.6× 75 0.4× 81 0.9× 45 682
Louis L. Radulovic United States 16 224 0.7× 171 0.8× 219 1.0× 128 0.8× 299 3.2× 25 973
Käte Franke United States 13 178 0.6× 144 0.7× 131 0.6× 124 0.7× 99 1.1× 19 748
P. R. Bieck Germany 19 225 0.7× 320 1.5× 96 0.4× 310 1.9× 238 2.5× 73 1.2k
P.L. Morselli France 18 255 0.8× 165 0.8× 275 1.3× 151 0.9× 118 1.3× 44 975
H. G. Giles Canada 15 139 0.4× 161 0.7× 106 0.5× 89 0.5× 59 0.6× 33 703

Countries citing papers authored by H. Mengel

Since Specialization
Citations

This map shows the geographic impact of H. Mengel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Mengel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Mengel more than expected).

Fields of papers citing papers by H. Mengel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Mengel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Mengel. The network helps show where H. Mengel may publish in the future.

Co-authorship network of co-authors of H. Mengel

This figure shows the co-authorship network connecting the top 25 collaborators of H. Mengel. A scholar is included among the top collaborators of H. Mengel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Mengel. H. Mengel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Søgaard, Birgitte, H. Mengel, Niranjan Rao, & Frank Larsen. (2005). The Pharmacokinetics of Escitalopram After Oral and Intravenous Administration of Single and Multiple Doses to Healthy Subjects. The Journal of Clinical Pharmacology. 45(12). 1400–1406. 112 indexed citations
2.
Thal, L. J., et al.. (2000). Lu 25-109, a muscarinic agonist, fails to improve cognition in Alzheimer’s disease. Neurology. 54(2). 421–421. 44 indexed citations
3.
Sramek, John J., et al.. (1997). A BRIDGING STUDY OF LU 25-109 IN PATIENTS WITH PROBABLE ALZHEIMER'S DISEASE. Life Sciences. 62(3). 195–202. 10 indexed citations
4.
Jansen, J. A., et al.. (1997). The Pharmacokinetics of Tiagabine in Healthy Elderly Volunteers and Elderly Patients with Epilepsy. The Journal of Clinical Pharmacology. 37(11). 1015–1020. 30 indexed citations
5.
Richens, A., David Chadwick, John S. Duncan, et al.. (1995). Adjunctive treatment of partial seizures with tiagabine: A placebo-controlled trial. Epilepsy Research. 21(1). 37–42. 78 indexed citations
6.
Gustavson, Linda E. & H. Mengel. (1995). Pharmacokinetics of Tiagabine, a γ‐Aminobutyric Acid‐Uptake Inhibitor, in Healthy Subjects After Single and Multiple Doses. Epilepsia. 36(6). 605–611. 78 indexed citations
7.
Mengel, H.. (1994). Tiagabine. Epilepsia. 35(s5). S81–4. 34 indexed citations
8.
Dalhoff, Kim, Thomas Almdal, K. Bjerrum, et al.. (1991). Pharmacokinetics of paroxetine in patients with cirrhosis. European Journal of Clinical Pharmacology. 41(4). 351–354. 29 indexed citations
9.
Andersen, Birgitte, et al.. (1991). No influence of the antidepressant paroxetine on carbamazepine, valproate and phenytoin. Epilepsy Research. 10(2-3). 201–204. 58 indexed citations
10.
Kŕause, W. & H. Mengel. (1990). Pharmacokinetics of the anxiolytic beta-carboline derivative abecarnil in the mouse, rat, rabbit, dog, cynomolgus monkey and baboon. Studies on species differences.. PubMed. 40(5). 522–9. 12 indexed citations
11.
Lundmark, Jöns, et al.. (1989). Paroxetine: pharmacokinetic and antidepressant effect in the elderly. Acta Psychiatrica Scandinavica. 80(S350). 76–80. 43 indexed citations
12.
Kŕause, W., H. Mengel, & Lars Nordholm. (1989). Determination of β-Carboline Derivatives in Biological Samples by High-Performance Liquid Chromatography with Fluorescence Detection. Journal of Pharmaceutical Sciences. 78(8). 622–626. 11 indexed citations
13.
Köhler, H., A. Schafmayer, R. Nustede, & H. Mengel. (1989). The Influence of the Duodenal Passage on Postprandial Neurotensin Release in Dogs. Hormone and Metabolic Research. 21(7). 351–355. 1 indexed citations
14.
Nordholm, Lars & H. Mengel. (1989). Determination of an oxadiazole-substituted 1,4-benzodiazepine in plasma by high-performance liquid chromatography with ultraviolet detection and by a radioreceptor assay. Journal of Chromatography B Biomedical Sciences and Applications. 494. 257–265. 4 indexed citations
15.
Gjerris, Annette, et al.. (1986). Femoxetine and cimetidine: Interaction in healthy volunteers. European Journal of Clinical Pharmacology. 31(3). 299–302. 1 indexed citations
16.
Bundgaard, Henning, et al.. (1984). Formation, bioavailability and organoleptic properties of an inclusion complex of femoxetine with β-cyclodextrin. International Journal of Pharmaceutics. 21(1). 51–60. 11 indexed citations
17.
Hansen, Bent Adel, H. Mengel, Susanne Keiding, & Jørgen Lund. (1984). Femoxetine Clearance in Patients with Liver Cirrhosis. Acta Pharmacologica et Toxicologica. 55(5). 386–390. 1 indexed citations
18.
Keiding, Susanne, H. Mengel, & Jacob Lund. (1983). Hepatic Elimination of Femoxetine in Pig during Intravenous Infusion. Acta Pharmacologica et Toxicologica. 52(3). 234–237. 2 indexed citations
19.
Lund, Jacob, Per Thayssen, H. Mengel, et al.. (1982). Paroxetine: Pharmacokinetics and Cardiovascular Effects after Oral and Intravenous Single Doses in Man. Acta Pharmacologica et Toxicologica. 51(4). 351–357. 19 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. L. Jack Breakdown of academic impact, for papers by K. H. Antonin Breakdown of academic impact, for papers by M. Gerna Breakdown of academic impact, for papers by F. Bengtsson Breakdown of academic impact, for papers by Morselli Pl Breakdown of academic impact, for papers by Louis L. Radulovic Breakdown of academic impact, for papers by Käte Franke Breakdown of academic impact, for papers by P. R. Bieck Breakdown of academic impact, for papers by P.L. Morselli Breakdown of academic impact, for papers by H. G. Giles
Rankless by CCL
2026